Kyowa Kirin Co Ltd's Fiscal Year is From January To December - All Figures are in JPY, Billions.
The item "Free-Cash-Flow-To-Equity" stands at -51.58 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the lowest value at least since 12/31/2011, the period currently displayed.'
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -62.89 Billion Japanese Yens compared to the value the year prior.
The 1 year change is -62.89 Billion Japanese Yens.
The 3 year change is -111.99 Billion Japanese Yens.
The 5 year change is -75.16 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Free Cash Flow To Equity | 905,699,262,464.00 |
![]() | Johnson & Johnson - Free Cash Flow To Equity | 486,508,953,600.00 |
![]() | AbbVie Inc - Free Cash Flow To Equity | 399,570,305,024.00 |
![]() | Roche Holding AG - Free Cash Flow To Equity | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Free Cash Flow To Equity | 280,205,508,085.11 |